New York State Common Retirement Fund’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Sell |
12,855
-8,900
| -41% | -$99.7K | ﹤0.01% | 2392 |
|
|
2025
Q1 | $99K | Hold |
21,755
| – | – | ﹤0.01% | 2525 |
|
|
2024
Q4 | $123K | Hold |
21,755
| – | – | ﹤0.01% | 2510 |
|
|
2024
Q3 | $105K | Hold |
21,755
| – | – | ﹤0.01% | 2562 |
|
|
2024
Q2 | $106K | Sell |
21,755
-375
| -2% | -$1.83K | ﹤0.01% | 2736 |
|
|
2024
Q1 | $294K | Buy |
22,130
+479
| +2% | +$6.36K | ﹤0.01% | 2286 |
|
|
2023
Q4 | $302K | Sell |
21,651
-1,382
| -6% | -$19.3K | ﹤0.01% | 2287 |
|
|
2023
Q3 | $305K | Buy |
23,033
+199
| +0.9% | +$2.64K | ﹤0.01% | 2240 |
|
|
2023
Q2 | $428K | Sell |
22,834
-2,164
| -9% | -$40.6K | ﹤0.01% | 2158 |
|
|
2023
Q1 | $360K | Sell |
24,998
-5,687
| -19% | -$81.9K | ﹤0.01% | 2345 |
|
|
2022
Q4 | $594K | Buy |
30,685
+43
| +0.1% | +$832 | ﹤0.01% | 2227 |
|
|
2022
Q3 | $1.05M | Buy |
30,642
+3,681
| +14% | +$126K | ﹤0.01% | 1946 |
|
|
2022
Q2 | $412K | Buy |
26,961
+114
| +0.4% | +$1.74K | ﹤0.01% | 2444 |
|
|
2022
Q1 | $613K | Sell |
26,847
-2,660
| -9% | -$60.7K | ﹤0.01% | 2319 |
|
|
2021
Q4 | $1.09M | Buy |
29,507
+13,148
| +80% | +$485K | ﹤0.01% | 2079 |
|
|
2021
Q3 | $769K | Buy |
+16,359
| New | +$769K | ﹤0.01% | 2235 |
|